Belhaven Biopharma

Raleigh, United States

Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.

$10.0M raised

Aug 2025

Series A

Biotechnology Clinical Trials Pharmaceutical

Top Investors

North Carolina Biotechnology Center

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Belhaven Biopharma

How much funding has Belhaven Biopharma raised?

Belhaven Biopharma has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.

Who are Belhaven Biopharma's investors?

Belhaven Biopharma's investors include North Carolina Biotechnology Center.

Where is Belhaven Biopharma headquartered?

Belhaven Biopharma is headquartered in Raleigh, United States.

What does Belhaven Biopharma do?

Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.

What stage is Belhaven Biopharma at?

Belhaven Biopharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 19, 2025.

MLA

"Belhaven Biopharma — Funding & Investors." VCBacked, August 19, 2025, https://www.vcbacked.co/company/belhaven-biopharma. Accessed July 2, 2026.

APA

VCBacked. (2025). Belhaven Biopharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/belhaven-biopharma

Wikipedia (cite web)

{{cite web |title=Belhaven Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/belhaven-biopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 19, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K